Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Karolinska Institutet, Department of Clinical Sciences, Stockholm, Sweden; Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden.
JACC Cardiovasc Imaging. 2021 Sep;14(9):1774-1783. doi: 10.1016/j.jcmg.2021.02.021. Epub 2021 Apr 14.
The objective of the SMINC-2 (Stockholm Myocardial Infarction With Normal Coronaries 2) study was to determine if more than 70% of patients with myocardial infarction with nonobstructed coronary arteries (MINOCA), investigated early with comprehensive cardiovascular magnetic resonance (CMR), could receive a diagnosis entirely by imaging.
The etiology of MINOCA is heterogeneous, including coronary, cardiac, and noncardiac causes. Patients with MINOCA, therefore, represent a diagnostic challenge where CMR is increasingly used.
The SMINC-2 study was a prospective study of 148 patients with MINOCA imaged with 1.5-T CMR with T and extracellular volume mapping early after hospital admission, compared to 150 patients with MINOCA imaged using 1.5-T CMR without mapping techniques from the SMINC-1 study as historic controls.
CMR was performed at a median of 3 (SMINC-2) versus 12 (SMINC-1) days after hospital admission. In total, 77% of patients received a diagnosis with CMR imaging in the SMINC-2 study compared to 47% in the SMINC-1 study (p < 0.001). Compared to SMINC-1, CMR in SMINC-2 detected higher proportions of myocarditis (17% vs. 7%; p = 0.01) and takotsubo syndrome (35% vs. 19%; p = 0.002) but similar proportions of myocardial infarction (22% vs. 19%; p = 0.56) and other cardiomyopathies (3% vs. 2%; p = 0.46).
The results of the SMINC-2 study show that 77% of all patients with MINOCA received a diagnosis when imaged early with CMR, including advanced tissue characterization, which was a considerable improvement in comparison to the SMINC-1 study. This supports the use of early CMR imaging as a diagnostic tool in the investigation of patients with MINOCA. (Stockholm Myocardial Infarction With Normal Coronaries [SMINC]-2 Study on Diagnosis Made by Cardiac MRI [SCMINC-2]; NCT02318498).
SMINC-2(斯德哥尔摩无阻塞性冠状动脉心肌梗死 2 期)研究的目的是确定在接受全面心血管磁共振(CMR)早期检查的非阻塞性冠状动脉心肌梗死(MINOCA)患者中,是否有超过 70%的患者可以仅通过影像学检查来明确诊断。
MINOCA 的病因具有异质性,包括冠状动脉、心脏和非心脏原因。因此,MINOCA 患者的诊断具有挑战性,CMR 的应用也越来越广泛。
SMINC-2 是一项前瞻性研究,纳入了 148 例在入院后早期接受 1.5-T CMR 检查并进行 T 及细胞外容积成像的 MINOCA 患者,将其与 150 例来自 SMINC-1 研究、在入院后早期接受 1.5-T CMR 检查但未采用成像技术的 MINOCA 患者作为历史对照。
SMINC-2 研究中 CMR 检查的中位时间为入院后 3 天,SMINC-1 研究中 CMR 检查的中位时间为入院后 12 天。SMINC-2 研究中,77%的患者通过 CMR 检查得到了明确诊断,而 SMINC-1 研究中为 47%(p<0.001)。与 SMINC-1 研究相比,SMINC-2 研究中 CMR 检测到更高比例的心肌炎(17%比 7%;p=0.01)和 Takotsubo 综合征(35%比 19%;p=0.002),而心肌梗死(22%比 19%;p=0.56)和其他心肌病(3%比 2%;p=0.46)的比例相似。
SMINC-2 研究结果表明,当对 MINOCA 患者进行早期 CMR 检查并进行高级组织特征成像时,77%的患者能够明确诊断,这与 SMINC-1 研究相比有了显著的改善。这支持将早期 CMR 成像作为 MINOCA 患者诊断工具的使用。(斯德哥尔摩无阻塞性冠状动脉心肌梗死[SMINC]-2 期研究:基于心脏 MRI 的诊断[SCMINC-2];NCT02318498)。